Intelligent – Concise – Entertaining
BridgePoint Bio partners with biotech organizations to serve as an advisor and educator.
Our educational courses help build culture and community around biotech organizations. Bridgepoint is focused on advanced medicines that offer transformative therapies for patients.
News & Insights
Read The Latest Posts From Our Newsletter.
Our newsletter tracks recent developments in the biotech industry. We explore genetic medicine, AI in biotech and the examine the breakthrough science that is driving our new, advanced medicines.
Kevin Curran, the Bridgepoint Bio founder, is the author of our newsletter. Visit this link to sign up for Kevin’s substack newsletter.
How does the new gene editing drug work?
I present a short video describing how Casgevy works for Sickle Cell Disease
Watch my you tube video on gene editing challenges
I discuss a recent safety issue with base editing technology
Everything you wanted to know about gene editing*
* but were afraid to ask
New gene therapy grabs headlines with a $4.25M price tag, but the science is the real story
Lenmeldy therapy genetically engineers bone marrow cells... these cells then travel to the brain to resolve a genetic disorder